Author of

• 28327

  +

  23 - FGFR/PDGFR/Angiogenesis (ID 23)

  • Event: TTLC 2019
  • Type: General Session
  • Track:
  • Presentations: 1
  • Moderators:Edward Kaftan, David Stewart
  • Coordinates: 2/23/2019, 09:50 - 10:45, Starlight Ballroom

  • 28540

    +

    Phase 1B Study of TRC 105 (Carotuximab) in Combination with Nivolumab in Patients with Metastatic NSCLC (ID 23.07)

    09:50 - 10:45  |  Author(s): Francisco Robert
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.